Healthcare & Life Sciences
Ray Therapeutics
United Statesraytherapeutics.com/
Ray Therapeutics is a seed startup based in United States. 2 investors tracked.
Activeseries-b
series-b
Stage
2018
Founded
4
Investors
About Ray Therapeutics
Ray Therapeutics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Ray Therapeutics is a clinical-stage biotechnology company developing optogenetic medicines to preserve and restore vision for patients with degenerative retinal diseases including retinitis pigmentosa, Stargardt’s disease, and geographic atrophy.
Explore Ray Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.